Recent Posts

• FDA approves DCCR, now Vykat XR, to ease hyperphagia in PWS
• Gene-editing tool successfully reactivates genes in PWS lab study
• Phase 2 trial testing setmelanotide for PWS set to start soon
• FDA delays approval decision until March on DCCR for excessive hunger in PWS
• Healthcare utilization, complexity higher in PWS hospitalizations
• FDA sees no need for DCCR advisory committee meeting
• Soleno’s DCCR under FDA priority review for hyperphagia in PWS
• CSTI-500 earns FDA’s rare pediatric disease designation for PWS
• Soleno files for US approval of DCCR for hyperphagia
• Seizures more likely in PWS caused by genetic deletion mutations